Morgan Stanley Downgrades Fractyl Health Inc (GUTS) to Equalweight

Morgan Stanley analyst Michael E Ulz downgraded Fractyl Health Inc (NASDAQ: GUTS) from Overweight to Equalweight with a price target of $2.00 (from $8.00).

The analyst comments "Randomized 6mo results for Revita in weight maintenance showed trends, but fell short of expectations, raising questions. While we continue to believe success in the pivotal study is possible (data 2H26), we take a more cautious view on the potential of Revita and move to the sidelines."

For an analyst ratings summary and ratings history on Fractyl Health Inc click here. For more ratings news on Fractyl Health Inc click here.

Shares of Fractyl Health Inc closed at $1.83 yesterday.

You May Also Be Interested In

• Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
• Birkenstock Holding plc (BIRK) PT Raised to $44 at Morgan Stanley
• Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer